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The activity of the catecholamine transporter of chromaffin granules and the binding to these vesicles of 
reserpine, a transporter inhibitor, decrease during ghost preparation. In contrast, the number of binding 
sites of dihydrotetrabenazine, another transporter ligand, is constant. Dihydrotetrabenazine thus binds to 
an inactive transporter whereas reserpine binds only to active vesicles. Inactivation occurs during lysis of 
the granules, possibly because of an incomplete resealing. The turnover number of the transporter, deter- 
mined by dividing the uptake activity by the density of dihydrotetrabenazine binding sites, has a maximal 
value (140 molecules/min) in intact granules. The reserpine to dihydrotetrabenazine binding ratio (10-2596) 
is an estimate of the proportion of correctly resealed vesicles. 
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1. INTRODUCTION 
Catecholamines are transported into chromaffin 
granules by a specific transporter, which catalyzes 
a monoamine/H+ antiport [ 1,2]. The transport is 
driven by an ATP-dependent H+-pump, which 
generates a H+ chemical gradient, A/H+, inside 
positive and acidic. The monoamine transporter is 
inhibited by the amine depleting drugs, TBZ and 
RES [3]. Both drugs bind to the transporter, but 
on distinct sites [4-61. [3H]RES binding requires 
the presence of a ApH+, whereas that of 
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In a previous communication [5], we have 
shown that [3H]TBZOH and [‘HIRES binding 
sites have similar densities on intact chromaffin 
granules, but that high-affinity [3H]RES binding 
sites are 5-lo-times less abundant on purified 
chromaffin granule membranes. Titration of the 
transport activity by the two drugs, on intact 
granules and on purified membranes, suggested 
that the loss of RES sites was associated with an in- 
activation of the monoamine transporter during 
membrane purification [5]. This hypothesis has 
now been examined more carefully. 
2. MATERIALS AND METHODS 
2.1. Chemicals 
Abbreviations: TBZ, tetrabenazine; TBZOH, dihydro- l-[7,8-3H]Noradrenaline acetate was obtained 
tetrabenazine (Zhydroxy-3-isobutyl-9,10-dimethoxy- from the Radiochemical Center (Amersham, 
1,2,3,4,6,7-hexahydro-lib(H) benzo [a] quinolizine); England) and was diluted to a specific activity of 
13H]TBZOH, [2-‘Hldihydrotetrabenazine; RES, reser- 20000 cpm/mmol. [benzoyl-‘H]Reserpine (24.4 
pine; ApH+, proton electrochemical gradient Ci/mmol) was from New England Nuclear 
[3H]TBZOH, a TBZ derivative, is independent of 
ApH+ generation. 
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(Boston, MA). Because of rapid radiolysis, the 
product was periodically repurified by HPLC 151. 
[‘HITBZOH (10.4 Ci/mmol) was prepared as 
described [7]. 
2.2. Preparation of chromaffin granules 
Chromaffin granules were obtained from a low 
speed supernatant (1000 x g for 10 min) of a 
bovine adrenal medullae homogenate. A ‘crude’ 
granule preparation (fraction P2) was prepared by 
differential centrifugation of the supernatant at 
27000 and 21000 x g for 30 min in 0.3 M sucrose, 
10 mM Hepes(Na+), pH 7.0. Further purification 
of the granules was performed by centrifugation 
(180000 x g for 1 h) on a 1.6 M sucrose layer [8]. 
The pellets thus obtained were frozen at -20°C 
before lysis. 
2.3. Preparation of ghosts 
The thawed purified granule pellets or the PZ 
fraction were added dropwise to a chilled 
hypotonic solution containing 2 mM MgS04, 
0.1 mM dithiothreitol and 5 mM Hepes(Na+), pH 
7.0. The suspension was stirred for 10 min and 
centrifuged at 40000 x g for 30 min. The pellets 
were washed by the same medium. In some ex- 
periments, MgS04 and dithiothreitol were omitted. 
2.4. Transport of pH]noradrenaline 
Chromaffin granules or ghosts (lo-20 ,ug pro- 
tein/ml) were preincubated for 5 min at 30°C in 
50 mM Hepes(Na+), pH 7.5, buffer containing 
0.3 M sucrose, 5 mM ATP and 2.5 mM MgS04. 
Uptake was initiated by the addition of 
[3H]noradrenaline (l-100 /cM, final concentra- 
tion). Aliquots (0.3 ml) were withdrawn during the 
first 15 min, diluted IO-fold with chilled 0.3 M 
sucrose buffered at pH 7.5 and filtered through 
HAWP 0.45 pm filters (Millipore). Filters were 
washed and their radioactivity determined by li- 
quid scintillation. Non-specific uptake, determined 
by addition of 4 PM TBZ to the assay, was sub- 
tracted. The kinetic parameters K, and Max of the 
uptake were determined by linear regression of the 
data on a Eadie-Hofstee plot. 
2.5. Binding of PHITBzOH and SHIRES 
[3H]TBZOH was assayed by filtration through 
HAWP 0.45 pm Millipore filters after incubation 
of the ligand with membranes or granules 
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(15-30rg protein/ml) for 2 h at 30°C in 0.3 M 
sucrose buffered at pH 7.5. Non-specific binding, 
determined by addition of 2 FM TBZ to the assay, 
was subtracted [4]. The parameters of the binding 
Kd and Bmax were determined by linear regression 
of the data on a Scatchard plot. 
For [‘HIRES binding, granules or membranes 
(15-30 pg protein/ml) were incubated with 3.5 nM 
13H]RES for 90 min at 30°C in 0.3 M sucrose, 
50 mM Hepes(Na+), pH 7.5, containing 2.5 mM 
ATP and 1.25 mM MgS04. Non-specific binding, 
determined in the presence of 1 /IM RES, was sub- 
tracted. At the concentration of [3H]RES used, 
specific [3H]RES binding was assumed to reflect 
the density of the high-affinity RES binding sites 
[51. 
2.6. Cytochrome b-56 
Cytochrome b-56 was assayed spec- 
trophotometrically with chromaffin granules 
(2 mg protein/ml) or ghosts (1 mg protein/ml) as 
described in [9]. 
2.7. Analytical procedures 
Protein concentration was measured according 
to the Lowry procedure with bovine serum 
albumin as a standard. Catecholamines were 
assayed essentially as described by Von Euler and 
Lishajko [lo]. 
3. RESULTS 
3.1. Inactivation of the monoamine transporter 
during chromaffin granule ghost preparation 
Our routine preparation of chromaffin granule 
ghosts involves four main steps: (i) preparation of 
a large granule fraction (Pz) by differential cen- 
trifugation; (ii) purification of the granules by cen- 
trifugation on a discontinuous sucrose gradient; 
(iii) lysis of the purified granules; (iv) freezing of 
the purified membranes. In a first set of ex- 
periments, the activity of the monoamine 
transporter, derived from measurements of ATP- 
dependent [3H]noradrenaline uptake, was deter- 
mined at various steps of the purification pro- 
cedure (table 1). The material obtained after the 
discontinuous sucrose gradient (step ii) was not 
tested since the corresponding granules are known 
to lyze when resuspended in 0.3 M sucrose. The 
density of [3H]TBZOH binding sites of the same 
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Table 1 
Inactivation of the monoamine transporter during ghost 
preparation 
Crude Purified Frozen 
granules membranes membranes 
[3H]Noradrenaline 
uptake 
Km WI) 18.5 
V,,, (pmol/min 
per mg prot.) 1667 
t3H]TBZOH 
binding 
Ka (nM) 1.8 
B,, (pmol/mg 
prot .) 12.2 
Cytochrome b-561 
(pmol/mg prot.) 660 
V,,/cytochrome 
(min-r) 2.53 
B,,,/cytochrome 0.019 
Turnover number 
V,,JB,, 
(min- ‘) 137 
4.3 4.7 
984 772 
2.9 3.1 
65.3 69.9 
3800 3300 
0.26 0.23 
0.017 0.021 
15 11 
fractions was also measured, as well as their con- 
tent of cytochrome b-561, a marker of chromaffin 
granule membrane. 
The results of table 1 show no significant varia- 
tion between the second and the third column, thus 
indicating that freezing does not affect the various 
activities of chromaffin granule membranes. The 
comparison of the first and second columns shows 
a different situation. The specific activity of the 
monoamine transporter, measured by the V,, of 
the ATP-induced [3H]noradrenaline uptake reac- 
tion, decreases by a factor of 1.7, though these 
steps correspond to a purification of the granules 
and to a loss of protein from the matrix. The high 
K,,, value obtained for the Pz fraction may be at- 
tributed to a contamination of the medium by en- 
dogenous catecholamines, which are present at 
high concentrations in the granule matrix. For the 
same samples, a 5.4-fold increase of the density of 
t3H]TBZOH binding sites B, was noted, in- 
dicating a purification of chromaffin granule 
membranes. The equilibrium dissociation constant 
Kd for [3H]TBZOH binding did not vary 
significantly throughout the purification pro- 
cedure, a result consistent with the fact that 
catecholamines are very inefficient in displacing 
[‘HITBZOH from its site [4]. 
Cytochrome b-561 is a marker of chromaffin 
granule membrane and its specific activity in- 
creases during the purification procedure (table 1). 
This marker has been used to assess the content of 
active transporter and of [3H]TBZOH binding site 
of chromaffin granules and of membranes. The 
relative activity of the transporter (V,,,/ 
cytochrome b-561) decreased dramatically (!WYo) 
during the preparation of the membranes. In con- 
trast, the relative number of [3H]TBZOH binding 
sites (&.Jcytochrome b-561) was constant during 
the same purification steps. 
Assuming that there is one [3H]TBZOH binding 
site per transporter molecule, the V,,,,/B,,, ratio 
is a measurement of the molecular turnover of the 
transporter. Our results indicate a decrease of the 
turnover number during the purification procedure 
and suggest a figure of 140 molecules of 
noradrenaline per minute for intact granules. 
3.2. The inactivation of the transporter is 
associated with the lysis resealing step 
To identify precisely the origin of the observed 
decrease of molecular turnover, an aliquot of the 
crude chromaffin granule fraction Pz was lyzed by 
osmotic shock and analyzed for [‘H]noradrenaline 
uptake and [3H]TBZOH binding (table 2, expt 1). 
After correcting the results for the loss of matrix 
protein occurring during lysis, the density of 
t3H]TBZOH binding sites was found to be con- 
stant. On the other hand, a 3.6-fold decrease of the 
transporter activity (V,,,) was observed. A similar 
inactivation was obtained when the granules were 
lyzed at 20°C. These results suggest hat the inac- 
tivation of the transporter shown in table 1 may be 
attributed to the osmotic lysis of chromaffin 
granules, and not to their purification by cen- 
trifugation through a hypertonic sucrose gradient. 
The lysis step resulted also in a decrease of high- 
affinity [3H]RES binding (table 2, expt 2). The 
ratio of [3H]RES binding to [3H]TBZOH binding 
decreased by a factor of 10 after lysis of crude 
granules. The same inactivation was observed 
when chromaffin granules were added to the 
hypotonic medium at 0 or 3O”C, or when this 
medium was added dropwise to the granule 
217 
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Table 2 
Effect of osmotic lysis on crude chromaffin granules 
Crude Lysed crude 
granules granules 
Expt 1 
Protein (mg/ml) 
Catecholamines (uM) 
[3H]TBZOH binding B,, 
(pmol/mg prot.) 
[3H]Noradrenaline uptake 
V max 
(pmol/min per mg prot.) 
Turnover number 
Vms~Bmax Onin-‘) 
Expt 2 
Protein (mg/ml) 
Catecholamines (uM) 
[‘HITBZOH binding 
B,, @mol/mg prot.) 
[3H]RES binding 
B,, (pmol/mg prot.) 
REWTBZ ratio 
6.75 3.36 
21000 28 
12.2 14.2a (28.3) 
1667 
137 32 
28 9.6 
24000 147 
3.2 5.6’ (16.5) 
2.5 0.4a (1.2) 
0.8 0.07 
457a (913) 
a Values corrected for the loss of matrix protein 
occurring during lysis. Uncorrected values are 
indicated in parentheses 
suspension. Assuming that one high-affinity 
[3H]RES binding site is associated with one 
[‘HITBZOH binding site and that [3H]RES binds 
only to active transporter molecules, the RES to 
TBZ binding ratio is an estimate of the active 
transporter molecules. 
4. DISCUSSION 
Our data indicate an inactivation of the 
monoamine transporter during our standard 
preparation of purified ghosts. This inactivation is 
important to consider for the calculation of the 
molecular turnover number of the transporter. 
Based on a V,,,, measured on ghost preparations, 
we have proposed a value of 35 molecules/min [4]. 
For intact granules, we now propose a value of 140 
molecules/min at 30°C (table 1). Such a figure in- 
dicates that the minimal time required to fill up a 
granule, possessing 20 transporter molecules [4], 
with 3 x lo6 catecholamine molecules [l l] is about 
18 h. If the cytosolic catecholamine concentration 
is assumed to be of the order of the Km of the 
transport reaction [12], this time is doubled to 
about 35 h in a noradrenergic hromaffin cell. In 
an adrenergic ell, a figure of 70 h may be propos- 
ed since two transport steps are required, the up- 
take of dopamine and that of adrenaline. These 
values are consistent with in vivo experiments, 
from which a filling time of 24-48 h was proposed 
t131. 
Our data show that the transporter is inactivated 
after the lysis step (table 2). The more likely ex- 
planation for this observation is an incomplete 
resealing of the lyzed vesicles. This would result in 
a loss of the vectorial properties of the open 
vesicles, such as monoamine transport or reserpine 
binding. It would not affect [3H]TBZOH binding, 
which is not A/cH+ dependent [5]. According to 
this hypothesis, only lo-25% of our membrane 
preparation is composed of right side-out vesicles. 
The proportion of sealed vesicles in a ghost 
preparation has been previously investigated by 
Hunter et al. [ 141. Using an elegant immunological 
approach, these authors concluded that 55% of 
their preparation was composed of correctly 
resealed ghosts, 11% of inside-out vesicles and 
34% of broken membranes. From a method- 
ological point of view, their approach was com- 
plicated by the fact that it required a standard of 
broken membranes. Our work suggests that the 
ratio of the densities of [3H]RES and [3H]TBZOH 
binding sites on a given preparation gives the 
percentage of correctly resealed ghosts, without 
any reference requirement. 
Though it is difficult to compare the various 
preparation techniques which have been assayed 
under different conditions, the preparation of 
Hunter et al. [14] seems to have a significantly 
higher uptake activity than ours (8 nmol 
5-HT/min per mg protein at 37’C). Assuming a 
density of transporter in their membrane prepara- 
tion comparable to ours (60 pmol/mg of protein), 
a molecular turnover number of 130 
molecules/min can be derived from their data, 
which is similar to the value that we propose for in- 
tact granules. This high value is consistent with a 
high proportion of correctly resealed ghosts. Carty 
et al. [15] have also described a preparation of 
ghosts with a high specific activity (5 and 
13 nmol/min per mg protein for 5-HT and 
noradrenaline, respectively); however, their activi- 
ty was measured under different conditions (KC1 
218 
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medium), and by a different technique 
(amperometry), and is thus difficult to compare 
with that of our preparations. Other groups have 
reported activities more comparable to ours 
[la-191. Further work will be required to deter- 
mine if the protocols of Hunter et al. [14] and Car- 
ty et al. [15] involve some critical step, either 
increasing the proportion of resealed vesicles or 
decreasing the fragmentation of the chromaffin 
granule membrane. 
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